Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT01186133

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Conditions: Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty

Sex: All

Ages: 19 Years – N/A

Healthy volunteers: No

Enrollment: 50000

Sponsor: Seung-Jung Park

Location: Korean centres Multiple Locations

Summary

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Eligibility Criteria

Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several DES * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01186133). StuddyBuddy aggregates publicly available trial information.